Migraine monoclonal antibodies against CGRP change brain activity depending on ligand or receptor target – an fMRI studyHauke Basedau, Arne May, Marlene Schellong et al.|eLife|2022Cited by 69
Trigeminal sensory modulatory effects of galcanezumab and clinical response predictionKuan‐Po Peng, Arne May, Thalea Oppermann et al.|Pain|2022Cited by 17
High-Density Electroencephalography-Informed Multiband Functional Magnetic Resonance Imaging Reveals Rhythm-Specific Activations Within the Trigeminal Nociceptive NetworkHauke Basedau, Jan Mehnert, Arne May et al.|Frontiers in Neuroscience|2022Cited by 14
Double-blind, randomized, placebo-controlled study to evaluate erenumab-specific central effects: an fMRI studyHauke Basedau, Arne May, Kuan‐Po Peng et al.|The Journal of Headache and Pain|2024Cited by 8
Cycling multisensory changes in migraine: more than a headacheKuan‐Po Peng, Hauke Basedau, Arne May|Current Opinion in Neurology|2022Cited by 8